CD33-BINDENDE MITTEL

European patent · EP2625201 · In force

Register entry

Publication number
EP2625201
Application number
EP11764553
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Maintained in amended form
Filed
Oct 4, 2011
Published
Aug 14, 2013
Granted
Sep 7, 2016
Protection ends at the latest
Oct 3, 2031
Next annual fee due
Oct 31, 2026
IPC classes
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
Priority
EP 10186468 04.10.2010
PCT application
PCT/EP2011/067339 04.10.2011
PCT publication
WO2012/045752 12.04.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Apr 17, 2019

    Change

    Published in Swissreg on 17.04.2019

  6. Sep 7, 2016

    Granted

    Published in Swissreg on 07.09.2016

Parties

Holder

Boehringer Ingelheim International GmbH

Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventor

KONOPITZKY, Renate

55216 Ingelheim Am Rhein, DE

BORGES, Eric

55216 Ingelheim Am Rhein, DE

ADAM, Paul

55216 Ingelheim Am Rhein, DE

HEIDER, Karl-Heinz

55216 Ingelheim Am Rhein, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.